Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Up 34.2% in December

Incannex Healthcare Inc. (NASDAQ:IXHL) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totalling 62,400 shares, a growth of 34.2% from the December 15th total of 46,500 shares. Approximately 0.5% of the company’s stock are short sold. Based on an average daily volume of 31,300 shares, the short-interest ratio is presently 2.0 days.

Incannex Healthcare Stock Up 4.3 %

Shares of IXHL opened at $1.93 on Friday. Incannex Healthcare has a fifty-two week low of $1.50 and a fifty-two week high of $8.47. The company has a market cap of $34.05 million, a P/E ratio of -1.39 and a beta of 7.54. The firm’s 50 day moving average price is $1.93 and its 200 day moving average price is $2.01.

Institutional Trading of Incannex Healthcare

An institutional investor recently bought a new position in Incannex Healthcare stock. Virtu Financial LLC purchased a new position in shares of Incannex Healthcare Inc. (NASDAQ:IXHL) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 36,622 shares of the company’s stock, valued at approximately $73,000. Virtu Financial LLC owned 0.21% of Incannex Healthcare at the end of the most recent reporting period. Institutional investors own 0.43% of the company’s stock.

Incannex Healthcare Company Profile

Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.